{
    "abstract": "The introduction of a specific International Classification of Diseases code for rotavirus diarrhea in 1992 prompted examination of the National Hospital Discharge Survey (NHDS) for trends in rotavirus-associated hospitalizations among US children aged 1 month through 4 years. During was the most common pathogen identified, coded in 16.5% of diarrhea cases (n \u00c5 26,798/year), and tions of presumed noninfectious and viral etiology resembled those associated with rotavirus. Rotavi- rus was reported as a cause of diarrhea more frequently by hospitals that were large (\u00a7100 beds), proprietary-owned, or in the West/Midwest. Although these findings suggest incomplete detection of rotavirus diarrhea cases, the large number of rotavirus-associated hospitalizations underscores the need for vaccines and indicates that NHDS data could be used to monitor the impact of a US rotavirus immunization program.",
    "reduced_content": "Hospitalizations Associated with Rotavirus Diarrhea in the United States, 1993\nthrough 1995: Surveillance Based on the New ICD-9-CM Rotavirus-Specific\n \n \n \n \n \n \nThe introduction of a specific International Classification of Diseases code for rotavirus diarrhea\nin 1992 prompted examination of the National Hospital Discharge Survey (NHDS) for trends in\nrotavirus-associated hospitalizations among US children aged 1 month through 4 years. During\nwas the most common pathogen identified, coded in 16.5% of diarrhea cases (n \u00c5 26,798/year), and\ntions of presumed noninfectious and viral etiology resembled those associated with rotavirus. Rotavi-\nrus was reported as a cause of diarrhea more frequently by hospitals that were large (\u00a7100 beds),\nproprietary-owned, or in the West/Midwest. Although these findings suggest incomplete detection\nof rotavirus diarrhea cases, the large number of rotavirus-associated hospitalizations underscores\nthe need for vaccines and indicates that NHDS data could be used to monitor the impact of a US\nrotavirus immunization program.\nRecent trials involving tetravalent rhesus rotavirus vaccine States, based on extrapolation from a single prospective study\nof hospitalizations for rotavirus diarrhea in a birth cohort of\nhave demonstrated that it is safe and effective in preventing\nclinical illness associated with rotavirus [1, 2], and this vaccine 126 children followed for 2 years [6]. That report concluded\nthat a rotavirus vaccine was not a priority for the United States\nmay be licensed and approved for routine immunization of\ninfants in the United States in the near future. The need for a [7]. Two subsequent studies based on National Hospital Dis-\ncharge Survey (NHDS) data for diarrhea-associated hospital-\nrotavirus vaccine in developing countries is evident from the\nenormous morbidity and mortality associated with rotavirus izations have indicated that the disease burden of rotavirus\ndiarrhea may be substantially greater than the initial IOM esti-\ndiarrhea, which is estimated to cause one-third of all diarrhea-\nassociated hospitalizations and 873,000 deaths per year [3, 4]. mate [8, 9]. However, because the International Classification\nof Diseases--9th revision, clinical modification (ICD-9-CM)\nIn the United States, rotavirus results in relatively few deaths\nbut is the pathogen most commonly identified among children had no specific code for rotavirus, unique epidemiologic char-\nacteristics of rotavirus diarrhea--including the predisposition\nhospitalized with diarrhea [5]. Therefore, the decision to intro-\nduce rotavirus vaccines in the United States will likely be based for children 4\u00ad23 months of age, winter seasonality, and geo-\ngraphic migration of seasonal rotavirus peaks from the South-\non the expected reduction in severe and costly outcomes (i.e.,\nhospitalizations) associated with rotavirus diarrhea and the west to the Northeast United States [6, 10]--were used as\nproxy indicators to estimate the prevalence of rotavirus among\ncost-effectiveness of a vaccination program. Accurate informa-\ntion on the epidemiology of hospitalizations associated with hospitalizations associated with diarrhea. As a result, these\nestimates had the potential for bias because of the assumptions\nrotavirus diarrhea in the United States is essential to assess the\npotential benefit of a mass vaccination program and to monitor in estimating prevalence of disease by indirect methods.\nits impact. In October 1992, the designation of a specific ICD-9-CM\nIn 1985, the Institute of Medicine (IOM) estimated that ro- code for rotavirus (008.61) [11] provided the opportunity to\ntavirus caused \u00c723,000 hospitalizations each year in the United use rotavirus-specific data from the NHDS to assess its impor-\ntance as a cause of diarrhea among hospitalized children and\nto compare the epidemiologic features of diarrheal episodes\nPresented in part: 37th Interscience Conference on Antimicrobial Agents cific, or other etiologies. This report describes the epidemiology\nand Chemotherapy, Toronto, September\u00adOctober 1997.\nof rotavirus-associated hospitalizations in the United States for\nReprints or correspondence: Dr. U. Parashar, Viral Gastroenteritis Unit,\nN.E., Atlanta, GA 30333 (UAP2@CDC.GOV). for diarrhea of other etiologies, and discusses the implications\nThe Journal of Infectious Diseases 1998;177:13\u00ad7 for monitoring the impact of a vaccination program against\nThis article is in the public domain.\nMethods After the introduction of a specific ICD-9-CM code for rotav-\nirus, the proportion of hospitalizations of reported viral etiology\nthe NHDS through the National Center for Health Statistics\n(NCHS), Centers for Disease Control and Prevention [12]. The\nsumed infectious, presumed noninfectious, and bacterial etiol-\nNHDS consists of a representative sample of patient discharge\nogy declined by 3.8%, 2.1%, and 1.2%, respectively, over the\nrecords obtained from short-stay, nonfederal, general, and chil-\nsame period (table 1). The proportion of hospitalizations coded\ndren's hospitals in the United States. National estimates of total\nwith rotavirus increased each year after introduction of the new\nhospitalizations were weighted according to NCHS criteria and do\nnot include hospitalizations at federal facilities, including Indian rotavirus-specific code and accounted for 13.3%, 16.9%, and\nThe ICD-9-CM codes were used to extract hospitalizations of respectively. During this period, an estimated 80,393 hospital-\nchildren 1 month through 4 years of age with diarrhea listed as izations (26,798 hospitalizations per year) were associated with\none of the first three diagnoses on the NHDS record [11]. The rotavirus, for a crude annual rate of 13.7 rotavirus hospitaliza-\nICD-9-CM codes used included diarrhea of determined etiology\ntions per 10,000 children. The proportion of diarrhea-associated\nhospitalizations coded as rotavirus was similar among males\ndiarrhea of undetermined etiology, including those presumed to be\n(17.4% vs. 13.3%). Rotavirus-associated hospitalizations ac-\nrecords on the basis of the first three listed diagnoses because\nyear), and the mean duration of hospitalizations for rotavirus\nseveral studies suggested that these hospitalizations likely repre-\nsent patients hospitalized for treatment of diarrhea [13]. Rotavirus diarrhea was longer than that for diarrhea of other causes (3.4\nhospitalizations were then extracted as one of up to seven discharge vs. 2.7 days).\ndiagnoses listed on the selected diarrhea-associated NHDS record. We examined the proportion of diarrhea hospitalizations as-\nSince rotavirus was introduced as a new ICD-9-CM code (008.61) sociated with rotavirus among children in different age groups\nin October 1992, we selected for this study hospitalization data to determine the age-specific disease burden of rotavirus (table\n2). Overall, rotavirus accounted for 16.5% of hospitalizations\nfor diarrhea among children \u00f55 years of age. The proportion\nincluded because the ICD-9-CM code specifically classifies these\nwas low among children aged 1\u00ad6 months, greatest among\nas neonatal illnesses identified with distinct codes.\nchildren aged 7\u00ad35 months, and decreased among older chil-\nWe examined seasonality and trends in the children's hospital-\ndren. About 14% of the children who were hospitalized with\nrotavirus diarrhea were \u00f57 months of age, the age by which\nfor the hospitalizations reported with rotavirus-specific codes ver- all routine immunizations would have been administered, and\nsus codes specifying other possible etiologies. Hospitalization rates three-fourths were \u00f52 years, the period when a child is consid-\n(per 10,000) were calculated using the census population for chil- ered to be at greatest risk for severe rotavirus disease.\ntions over the 3-year study period by etiology and age group\nto determine seasonal and age-related trends (figure 1). Hospi-\nResults\ntalizations for rotavirus diarrhea occurred mainly during the\nwinter months (November through April) (figure 1A), similar\nestimated 487,433 diarrhea-associated hospitalizations were re- to those presumed to be noninfectious and of viral etiology\n(which together accounted for 79.5% of all diarrheal hospital-\nported among children aged 1 month through 4 years in the\nUnited States, an annual average of 162,478 hospitalizations izations), and had a more pronounced peak. In contrast, the\nremaining small fraction (4.4%) of hospitalizations specified\nper year (table 1). Overall, diarrheal illness were reported for\n13.5% of total hospitalizations among children in this age as bacterial or parasitic etiology peaked during the summer\nmonths. A marked winter seasonal peak in diarrheal hospital-\ngroup. The crude annual rate of diarrhea-associated hospitaliza-\nthis peak was less prominent among younger (1\u00ad3 months)\nhospitalized by the age of 5 years), and this accounted for\nTo assess possible differences in the coding and reporting\ntion). An estimated 158 deaths per year were reported among\nchildren hospitalized with diarrhea for a case-fatality rate of 1 of rotavirus diarrhea between hospitals included in the sampling\nframe of the NHDS, we examined the proportion of diarrheal\nassociated hospitalizations were of unspecified etiology; of the hospitalizations associated with rotavirus by hospital size, type\nof ownership, and geographic location. Rotavirus was coded\nremaining, viruses accounted for 32.9%, followed by bacteria\nNo. of hospitalizations (%)\nICD-9-CM Change\nEtiology unspecified\nEtiology specified\nNOTE. Overall diarrhea-associated diagnoses were 1 of first 3 listed on discharge record. ICD-9-CM, International Classification of Diseases--9th revision,\nclinical modification.\n* \u00fa1 diagnostic category (ICD-9-CM code) may be listed on each discharge record.\n Weighted hospitalizations determined from sampled hospitalizations.\n\u00a7 Excludes localized salmonella infections (003.2).\n\u00f5100 beds (10.2%), were proprietary-owned (28.7%) versus burden in order to determine the cost effectiveness and potential\nnonprofit (17.1%) or government-owned (8%), and were lo- benefits of universal vaccination and to establish a system to\ncated in the West (21.1%) and Midwest (19.6%) versus the monitor the impact of vaccines. This study, the first to use the\nSouth (15.8%) and Northeast (9.2%). recently introduced ICD-9-CM code for rotavirus diarrhea to\nassess national hospitalization data, addresses both issues. For\nmonitoring the impact of vaccines, we were surprised that even\nDiscussion in the first year of the introduction of a specific diagnostic\ncode, rotavirus was the most commonly reported pathogen for\nIn the prevaccine era, the two major goals of rotavirus sur-\nchildren hospitalized with diarrhea and accounted for 16.5%\nveillance have been to provide a better estimate of the disease\n(n \u00c5 26,798 per year) of all diarrhea-associated hospitalizations\nover the study period. This number is about half of the pre-\nTable 2. Age-specific proportion of reported gastroenteritis (GE)\nyear from national data for which no specific code was avail-\nhospitalizations associated with rotavirus (RV) among children aged\nized children indicate that about one-third of diarrhea cases are\nNo. of GE due to rotavirus, suggesting that about one-half of cases in the\nhospitalizations\nUnited States are currently being coded. In view of the rela-\nAge group No. of GE associated with Cumulative no. of RV\ntively high proportion of cases reported, existing hospital dis-\n(months) hospitalizations RV (%) hospitalizations (%)\ncharge data should provide a specific, robust, and sensitive tool\nOn the other hand, while our data on disease burden demon-\nstrate the importance of rotavirus as a cause of diarrhea among\nhospitalized children and underscore the need for effective vac-\naged from ordering diagnostic tests for rotavirus that increase\nFigure 1. Diarrhea-associated hospitalizations by (A) etiology and (B) age-group among children aged 1 through 59 months (M), by month\nthe cost of medical care but do not significantly alter treatment talizations attributed to rotavirus from 13.3% in 1993 to 18.9%\ndecisions. Consequently, much rotavirus infection may go un-\ndiagnosed and be coded as nonspecific diarrhea. This hypothe- This study of hospital discharge data has some important\nlimitations related to the sampling and coding procedures used.\nsis is supported by two observations. First, the proportion of\ndiarrheal hospitalizations associated with rotavirus differed by We may have underestimated the number of diarrhea-associ-\nated hospitalizations for the entire US population because the\nhospital size, region, and type of ownership, which suggests\npossible differences in the practices promoted for rotavirus sample excludes federal hospitals (e.g., Indian Health Service,\nmilitary, and Public Health Service hospitals), which often\ntesting. Second, hospitalizations of presumed noninfectious and\nviral etiology, which constituted 79.5% of diarrhea-associated serve populations with substantial diarrheal disease burden [12]\nand because the number of participating children's hospitals\nhospitalizations, exhibited a winter seasonality similar to those\nfor rotavirus. In a large study at Texas Children's Hospital varied over the study period. Also, the NHDS sample includes\nonly 0.5%\u00ad1.0% of all hospitalizations in the United States\n[5], one-third of diarrhea-associated hospitalizations coded as\npresumed noninfectious on the discharge records were attrib- [12]; consequently, our findings may not be representative of\nthe entire nation. In regard to coding, we assume that a report\nuted to rotavirus infection after the children's stool specimens\nwere screened. The disease burden of rotavirus diarrhea could of rotavirus on the hospital discharge record is based on estab-\nlishing a laboratory diagnosis, an assumption that needs to be\nbe further underestimated because of a lack of awareness of the\nrecently introduced ICD-9-CM diagnostic code, a hypothesis confirmed. However, the marked winter seasonality of reported\nrotavirus hospitalizations and their predisposition for children\nsupported by the continuous increase in the proportion of hospi-\nReferences\naged 4\u00ad35 months is consistent with observations from previ-\n1. Rennels MB, Glass RI, Dennehy PH, et al. Safety and efficacy of high-\nous studies of hospitalized children and laboratory detections\ndose rhesus-human reassortant rotavirus vaccines: report of the national\n[6, 10] and has given us some confidence that the estimates\nfor rotavirus diarrhea are reasonable and accurate.\n2. Bernstein DI, Glass RI, Rodgers G, Davidson BL, Sack DA. Evaluation\nIn conclusion, our findings indicate that rotavirus is the major of rhesus rotavirus monovalent and tetravalent reassortant vaccines in\ndefinable etiology of diarrhea among children hospitalized in\n3. Cook SM, Glass RI, LeBaron CW, Ho MS. Global seasonality of rotavirus\nthe United States and underscore the need for an effective\nvaccine. The epidemiologic trends of reported rotavirus hospi-\n4. Institute of Medicine. Prospects for immunizing against rotavirus. In: New\ntalizations were consistent with the indirect methods used pre- vaccine development: establishing priorities. Diseases of importance in\nviously to ascertain the national disease burden of rotavirus developing countries. Vol II. Washington, DC: National Academy Press,\nfrom nonspecific data on hospital discharges [8, 9] and confirm\n5. Matson DO, Estes MK. Impact of rotavirus infection at a large pediatric\nthat earlier estimates by Ho et al. [8] and Jin et al. [9] may be\nreasonable. Routine data on hospital discharges should provide\n6. Rodriguez WJ, Kim HW, Brandt CD, et al. Longitudinal study of rotavirus\na sensitive tool to monitor the impact of vaccines, but the infection and gastroenteritis in families served by a pediatric medical\npractice: clinical and epidemiologic observations. Pediatr Infect Dis\nincompleteness of identification and reporting of rotavirus, the\nlack of information on laboratory-confirmed cases, and the 2-\n7. Institute of Medicine. Prospects for immunizing against rotavirus. In: New\nyear delay in obtaining information are important limitations\nvaccine development: establishing priorities. Diseases of importance in\nof NHDS data. A network of sentinel hospitals that report the United States. Vol I. Washington, DC: National Academy Press,\n8. Ho MS, Glass RI, Pinsky PF, Anderson LJ. Rotavirus as a cause of\nrus diarrhea could provide more accurate information to assess\ndiarrheal morbidity and mortality in the United States. J Infect Dis\nthe disease burden but may be of limited value in monitoring\nthe impact of vaccines. More than 30 states have complete\n9. Jin S, Kilgore PK, Holman RC, Clarke MJ, Gangarosa EJ, Glass RI.\nreporting of hospital discharges that are more robust than na- Trends in hospitalizations for diarrhea in United States children from\ntional data, provide information with less delay, and could be\nused to augment national rotavirus surveillance. Finally, some\n10. LeBaron CW, Lew J, Glass RI, Weber JM, Ruiz-Palacios GM, Rotavirus\nlarge health maintenance organizations have computerized da-\nStudy Group. Annual rotavirus epidemic patterns in North America:\ntabases for medical outcomes (outpatient visits, emergency results of a five-year retrospective survey of 88 centers in Canada,\nroom visits, and hospitalizations) among large well-defined Mexico, and the United States. JAMA 1990;264:983\u00ad8.\n11. Public Health Service and Health Care Financing Administration. Interna-\ncohorts of enrolled children that could provide estimates of the\ntional classification of diseases, 1996. 9th revision. Clinical modifica-\nincidence of rotavirus diarrhea and be used to monitor the\nimpact of rotavirus vaccines.\n12. National Center for Health Statistics. National hospital discharge survey.\nMulti-year data tape information 1979\u00ad92. Hyattsville, MD: NCHS,\n13. Gangarosa RE, Glass RI, Lew JF, Boring JR. Hospitalizations involv-\ning gastroenteritis in the United States, 1985: the special burden\n"
}